Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R CRAWFORD

Showing results (751-760 of 774) with videos related to

Pageof 78
Sort By:
Acta Neuropathologica|December 6, 2019
Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trialsAnthony P Y Liu, Brian Gudenas, Tong Lin, et al.
International Journal of Medical Sciences|March 9, 2026
Integrin αvβ3 is a Potential Therapeutic Target in CholangiocarcinomaFitria Sari Wulandari, Chih-Yang Wang, Dana R Crawford, et al.
Acta Neuropathologica|December 23, 2019
Correction to: Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trialsAnthony P Y Liu, Brian Gudenas, Tong Lin, et al.
Cancer Cell|March 16, 2016
HDAC and PI3K Antagonists Cooperate to Inhibit Growth of MYC-Driven MedulloblastomaYanxin Pei, Kun-Wei Liu, Jun Wang, et al.
The Journal of Clinical Investigation|August 21, 2020
Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline gliomaSabine Mueller, Jared M Taitt, Javier E Villanueva-Meyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 19, 2022
Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003Cassie Kline, Payal Jain, Lindsay Kilburn, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|December 30, 2019
NDAT suppresses pro-inflammatory gene expression to enhance resveratrol-induced anti-proliferation in oral cancer cellsYih Ho, Chien-Yi Wu, Yu-Tang Chin, et al.
Nature Genetics|April 22, 2026
Systematic design of combination therapy by targeting master regulators of coexisting diffuse midline glioma cell statesEster Calvo Fernández, Lorenzo Tomassoni, Xu Zhang, et al.
Neuro-Oncology|April 13, 2019
Molecular grouping and outcomes of young children with newly diagnosed ependymoma treated on the multi-institutional SJYC07 trialSanthosh A Upadhyaya, Giles W Robinson, Arzu Onar-Thomas, et al.
International Journal of Cancer|March 13, 2019
A pilot precision medicine trial for children with diffuse intrinsic pontine glioma-PNOC003: A report from the Pacific Pediatric Neuro-Oncology ConsortiumSabine Mueller, Payal Jain, Winnie S Liang, et al.
Pageof 78

Showing results (751-760 of 774) with videos related to

Sort By:
Pageof 78
Acta Neuropathologica|December 6, 2019
Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trialsAnthony P Y Liu, Brian Gudenas, Tong Lin, et al.
International Journal of Medical Sciences|March 9, 2026
Integrin αvβ3 is a Potential Therapeutic Target in CholangiocarcinomaFitria Sari Wulandari, Chih-Yang Wang, Dana R Crawford, et al.
Acta Neuropathologica|December 23, 2019
Correction to: Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trialsAnthony P Y Liu, Brian Gudenas, Tong Lin, et al.
Cancer Cell|March 16, 2016
HDAC and PI3K Antagonists Cooperate to Inhibit Growth of MYC-Driven MedulloblastomaYanxin Pei, Kun-Wei Liu, Jun Wang, et al.
The Journal of Clinical Investigation|August 21, 2020
Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline gliomaSabine Mueller, Jared M Taitt, Javier E Villanueva-Meyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 19, 2022
Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003Cassie Kline, Payal Jain, Lindsay Kilburn, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|December 30, 2019
NDAT suppresses pro-inflammatory gene expression to enhance resveratrol-induced anti-proliferation in oral cancer cellsYih Ho, Chien-Yi Wu, Yu-Tang Chin, et al.
Nature Genetics|April 22, 2026
Systematic design of combination therapy by targeting master regulators of coexisting diffuse midline glioma cell statesEster Calvo Fernández, Lorenzo Tomassoni, Xu Zhang, et al.
Neuro-Oncology|April 13, 2019
Molecular grouping and outcomes of young children with newly diagnosed ependymoma treated on the multi-institutional SJYC07 trialSanthosh A Upadhyaya, Giles W Robinson, Arzu Onar-Thomas, et al.
International Journal of Cancer|March 13, 2019
A pilot precision medicine trial for children with diffuse intrinsic pontine glioma-PNOC003: A report from the Pacific Pediatric Neuro-Oncology ConsortiumSabine Mueller, Payal Jain, Winnie S Liang, et al.
Pageof 78